BRPI0716576A2 - Tratamento e prevenção de fibrose intestinal - Google Patents

Tratamento e prevenção de fibrose intestinal

Info

Publication number
BRPI0716576A2
BRPI0716576A2 BRPI0716576-5A2A BRPI0716576A BRPI0716576A2 BR PI0716576 A2 BRPI0716576 A2 BR PI0716576A2 BR PI0716576 A BRPI0716576 A BR PI0716576A BR PI0716576 A2 BRPI0716576 A2 BR PI0716576A2
Authority
BR
Brazil
Prior art keywords
prevention
treatment
intestinal fibrosis
fibrosis
intestinal
Prior art date
Application number
BRPI0716576-5A2A
Other languages
English (en)
Inventor
John Parkinson
Stefano Fiorucci
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of BRPI0716576A2 publication Critical patent/BRPI0716576A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BRPI0716576-5A2A 2006-08-23 2007-08-22 Tratamento e prevenção de fibrose intestinal BRPI0716576A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83975506P 2006-08-23 2006-08-23
PCT/EP2007/007567 WO2008022807A2 (en) 2006-08-23 2007-08-22 Lipoxin a4 analogs for the treatment and prevention of intestinal fibrosis

Publications (1)

Publication Number Publication Date
BRPI0716576A2 true BRPI0716576A2 (pt) 2014-02-18

Family

ID=39107156

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0716576-5A2A BRPI0716576A2 (pt) 2006-08-23 2007-08-22 Tratamento e prevenção de fibrose intestinal

Country Status (18)

Country Link
US (1) US20080119439A1 (pt)
EP (1) EP2056816A2 (pt)
JP (1) JP2010501506A (pt)
KR (1) KR20090042982A (pt)
CN (1) CN101528219A (pt)
AR (1) AR062478A1 (pt)
AU (1) AU2007287770A1 (pt)
BR (1) BRPI0716576A2 (pt)
CA (1) CA2660741A1 (pt)
CL (1) CL2007002442A1 (pt)
IL (1) IL196983A0 (pt)
MX (1) MX2009001994A (pt)
PE (1) PE20081360A1 (pt)
RU (1) RU2009110244A (pt)
TW (1) TW200816991A (pt)
UY (1) UY30557A1 (pt)
WO (1) WO2008022807A2 (pt)
ZA (1) ZA200902005B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011520929A (ja) * 2008-05-22 2011-07-21 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 結晶性の２−（（２ｓ，３ｒ，４ｅ，６ｅ，１０ｅ，１２ｓ）−１３−（４−フルオロフェノキシ）−２，３，１２−トリヒドロキシトリデカ−４，６，１０−トリエン−８−イニルオキシ）酢酸の無水及び水和物形態
IN2014MN00908A (pt) 2011-11-18 2015-04-17 Nitto Denko Corp
KR102437682B1 (ko) * 2016-06-03 2022-08-29 테티스 파마수티컬스 엘엘씨 특화된 사전 해소 매개체의 염에 관한 조성물 및 방법
EP3870169A4 (en) * 2018-10-23 2022-06-29 The Brigham and Women's Hospital, Inc. Lipoxin a4 analogs and uses thereof
KR20250043287A (ko) 2023-09-21 2025-03-28 오토텔릭바이오 주식회사 티아졸 유도체 화합물을 포함하는 장섬유화증 치료용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650435A (en) * 1991-04-01 1997-07-22 Madara; James L. Modulation of inflammation related to columnar epithelia
US5441951A (en) * 1994-06-15 1995-08-15 Brigham & Women's Hospital Lipoxin compounds
US6006466A (en) * 1998-08-20 1999-12-28 Washecka; John Concealed linear payout holder for fishing leader
US6831186B2 (en) * 2001-11-06 2004-12-14 Schering Aktiengesellschft Lipoxin A4 analogs

Also Published As

Publication number Publication date
CL2007002442A1 (es) 2008-03-14
ZA200902005B (en) 2010-05-26
JP2010501506A (ja) 2010-01-21
IL196983A0 (en) 2009-11-18
US20080119439A1 (en) 2008-05-22
KR20090042982A (ko) 2009-05-04
CA2660741A1 (en) 2008-02-28
WO2008022807A2 (en) 2008-02-28
AU2007287770A1 (en) 2008-02-28
CN101528219A (zh) 2009-09-09
PE20081360A1 (es) 2008-11-29
MX2009001994A (es) 2009-03-06
AR062478A1 (es) 2008-11-12
UY30557A1 (es) 2008-03-31
WO2008022807A3 (en) 2008-05-29
TW200816991A (en) 2008-04-16
RU2009110244A (ru) 2010-09-27
EP2056816A2 (en) 2009-05-13

Similar Documents

Publication Publication Date Title
PT2046324T (pt) Tratamento e prevenção de mucosite por derivados de antocianidina
BRPI0811142A2 (pt) Prevenção e tratamento de condições oculares associadas a complementos
PL2583978T3 (pl) Profilaktyka i leczenie chorób synukleinopatycznych i amyloidogennych
BRPI0716466A2 (pt) Tratamento da calda de açúcar
DK2104737T3 (da) Funktioner og formål for let-7 mikro-RNAer
EP1972256A4 (en) ENDOSCOPE AND ROTATING SELF-DRIVEN ENDOSCOPE
DE602007002740D1 (de) Trokar und Behandlungssystem
EP2368114A4 (en) PREDICTION AND PREVENTION OF PREECLAMPSY
EP1982660A4 (en) TREATMENT ENDOSCOPE
CR9878A (es) Tratamiento y profilaxis de microangiopatias
EP2124548A4 (en) DISINTEGRIN VARIANTS AND PHARMACEUTICAL USES THEREOF
BRPI0811870A2 (pt) Tratamento e prevenção de influenza
PL3067066T3 (pl) Zapobieganie i leczenie choroby synukleinopatycznej i amyloidogennej
ZA200901452B (en) Treatment of vertigo with acetyl-L-leucine
GB0610350D0 (en) prevention and/or treatment of neuodegenerative disorders
GB2445651B (en) Well treatment products and methods of using them
GB0608647D0 (en) Methods of diagnosis and treatment
IL196983A0 (en) Treatment and prevention of intestinal fibrosis
GB0619500D0 (en) Treatment of fibrosis
BRPI0715087A2 (pt) Método de tratamento de disfunção termoregulatória com paroxetina
ZA200708423B (en) Use of macrolides for treating intestinal inflammation
TWM300528U (en) Cleat structure of goggles
IL194798A0 (en) Treatment of melanoma
EP1937086A4 (en) PROCESSING OF FOODSTUFFS
GB0623740D0 (en) Treatment of disease

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]